H.U. Group Holdings is a holding company operating across three core segments: Lab Testing and Related Services (LTS), In-Vitro Diagnostics (IVD), and Healthcare-related Services (HS). The LTS segment, led by SRL Inc., provides clinical laboratory testing services to hospitals and clinics, including genetic testing in the U.S. via Baylor Miraca Genetics Laboratories. The IVD segment, operated through Fujirebio Holdings, develops and manufactures in-vitro diagnostic reagents including the LUMIPULSE fully automated chemiluminescent immunoassay system, sold globally through subsidiaries in Europe, the U.S., and Belgium, with a notable focus on neurodegenerative disease biomarkers such as Alzheimer's disease.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →H.U. Group Holdings is a holding company operating across three core segments: Lab Testing and Related Services (LTS), In-Vitro Diagnostics (IVD), and Healthcare-related Services (HS). The LTS segment, led by SRL Inc., provides clinical laboratory testing services to hospitals and clinics, including genetic testing in the U.S. via Baylor Miraca Genetics Laboratories. The IVD segment, operated through Fujirebio Holdings, develops and manufactures in-vitro diagnostic reagents including the LUMIPULSE fully automated chemiluminescent immunoassay system, sold globally through subsidiaries in Europe, the U.S., and Belgium, with a notable focus on neurodegenerative disease biomarkers such as Alzheimer's disease.
Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.
Free Demo (No Time Limit, 10 Companies) →